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THE CLINICAL PROFILE OF IDIOPATHIC PARKINSON’S 
DISEASE IN A SOUTH AFRICAN HOSPITAL COMPLEX - 
THE INFLUENCE OF ETHNICITY AND GENDER 
 
Marcelle Smith and Girish Modi 
 
Abstract: 
Idiopathic Parkinsons Disease (IPD) has not been well studied in Black African populations. 
Data on the demographics, phenotype differences with Caucasoid populations, severity and 
frequencies of IPD in Black Africans is scant.  
 
Aim: to determine the impact of ethnicity and gender on the phenotype of IPD in South 
African patients. 
 
Method: Fifty patients with diagnosed IPD were recruited. The data collection was in the 
form of a questionnaire and clinical evaluation which included a mental status examination 
(MMSE), and illness staging.  
 
Results: Thirty-five patients were Black African, eleven were white European descendant, 
three were of Indian descent and one had mixed ancestry. Twenty-eight of the patients were 
female. There were no significant gender differences within or between the different ethnic 
groups. Seventy- one percent of black and ninety-one percent of white participants had 
classic IPD presentations. A resting tremor was found in fifty-nine percent of all males in the 
study but in ninety-four percent of females. In the black IPD patients, thirty-one percent had 
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early onset IPD (age of onset less than 50 years) with a gender ratio of M:F=1:6. Twenty-nine 
percent had an akinetic-rigid syndrome with erect posture and no tremor (gender ratio of M:F 
= 7:4) and seventy-four had cognitive impairment (gender ratio of M:F =8:5). 
 
Conclusion: The phenotype of IPD in the majority of our study population is of the classic 
IPD type. In a third of our Black patients the onset was early and in a third the presentation 
was akinetic. 
 
Keywords: Parkinsons disease; Gender; Ethnicity 
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The profile of patients with Parkinson’s disease in a South 
African hospital complex- an institution based 
observational study. 
Introduction and literature review 
Idiopathic Parkinson’s disease (IPD) was first described by James Parkinson in 18171 and later his 
work was continued by Gowers and Charcot.  It is a slowly progressive, degenerative neurological 
disorder characterised by the syndrome of parkinsonism . This encompasses the cardinal features of 
bradykinesia, muscle rigidity, resting tremor, stooped posture and loss of postural reflexes with falls 
and freezing. There is little literature on IPD from South Africa, and Africa as a whole. Most available 
information is derived from European and North American populations.  
The diagnosis of IPD is made on clinical grounds. In 1988, Gibb and Lees developed the Queen 
Square Brain Bank (QSBB) criteria for PD, based on correlation of clinical features of IPD with 
pathological confirmation from post mortem examination of the brain2. In 1992, Hughes et al showed 
that only 76% of patients diagnosed IPD by UK neurologists had the neuropathological features 
diagnostic of the disease3. Retrospective application of the QSBB clinical criteria improved the 
diagnostic accuracy to 82%. The study was revisited in 2001 and showed that the clinical diagnosis 
accuracy had improved to 90%4. The QSBB criteria are highly sensitive and specific and so remain 
the benchmark for the diagnosis of IPD. Strict adherence to the criteria enables a reliable diagnosis. It 
is, however, important to note that not all patients will meet the full diagnostic criteria for IPD at 
initial presentation. 
The Queen’s Square Brain Bank (QSBB) criteria, entail a three step process. In the first step, a 
diagnosis of a syndrome of parkinsonism must be made.  
The hallmark of parkinsonism and essential criterion is the presence of bradykinesia. Additionally, the 
patient must have one of the following clinical features 
• muscle rigidity, resting tremor (4-6Hz), 
• postural instability that is not related to visual, cerebellar, vestibular or proprioceptive 
dysfunction. 
The second step is to apply exclusion criteria. These are chiefly derived from the patient’s history. 
These include the following: 
• Repeated strokes with stepwise progression 
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• Repeated head injury 
• Antipsychotics or Dopamine-depleting drugs 
• Definite encephalitis and/or oculogyric crisis on no drug treatment 
• More than one affected relative  
• Sustained remission 
• Negative response to large doses of levodopa (if malabsorption excluded) 
• Strictly unilateral features after 3 years 
• Other neurological features: supranuclear gaze palsy, cerebellar signs, early severe autonomic 
involvement, Babinski's sign, early severe dementia with disturbance of language, memory or 
praxis 
• Exposure to known neurotoxin 
• Presence of cerebral tumour or communicating hydrocephalus on neuroimaging 
The third step is to look for supportive criteria for IPD.  
The third step includes features that are supportive of IPD. Three or more of the following criteria are 
required: 
• Unilateral onset 
• Resting tremor present 
• Progressive disorder 
• Persistent asymmetry affecting the side of onset most 
• Excellent response to levodopa (70-100%) 
• Severe levodopa-induced chorea 
• Levodopa response for more than 5 years 
• Clinical course of over 10 years 
 
 
 
With advances in genetic research, many forms of Idiopathic Parkinson’s Disease have been found to 
result from genetic mutations in genes encoding alpha synuclein and the Parkin protein, among others. 
Up to 50% of patients with early onset IPD have the Parkin gene mutation. However, most cases are 
sporadic and of unknown aetiology. The disease arises from loss of neuromelanin-containing 
monoamine neurons, particularly dopaminergic neurons in the substantia nigra pars compacta. 
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 Van Eeden et al carried out a study to determine the incidence of IPD by age, ethnicity and gender5. 
This was the first study of its kind. Newly diagnosed patients between 1994 and 1995 from an large 
health maintenance organisation in Northern California, the Kaiser Permanente Medical Care 
Program, were included in the study. A total of 588 newly diagnosed IPD patients were identified 
from the membership information. These patients were diagnosed according to the modified Core 
Assessment Program for Intracerebral Transplantation/ Hughes criteria. There was an overall 
incidence rate of 13.4 per 100,000. This increased greatly over the age of sixty. The mean age at 
diagnosis was 70.5 (38-91) for both men and women. White patients were found to be older at 
diagnosis compared to Black, Hispanic and Asian participants. The annual incidence of Parkinson’s 
disease was 12.3% in people under 50 years old and 44% in those over 50.  Only 4% of cases overall 
had onset of disease before the age of 50. The rate of PD was 91% higher in men than in women.  
 
Wright Willis et al published an epidemiological study in 2010 which investigated the geographic and 
ethnic variation in PD6. The study population included patients who were Medicare users living in the 
USA in 1995 or between 2000 and 2005. Incidence and prevalence rates were determined by 
comparing the number of PD patients with the total number of Medicare users. The mean prevalence 
in users over the age of 65 years was 1.6% and the mean annual incidence of 1.85%. The mean 
prevalence slowly increased with age. The prevalence in Black and Asian users was 50% lower than 
in whites. It was also higher in urban areas than in rural areas. Black users also appeared to have a 
higher morbidity related to PD than White users. The question remains whether these results can be 
extrapolated to South African patients with PD, and whether PD found in our Black population is 
distinct from that found in white patients.  
Although some of the earliest reports of Parkinson’s -like disorders can be traced back as early as 
1350-1200 BC Egypt, little is known about Idiopathic Parkinson’s Disease in African populations. 
Most of what we know of the disease is derived from European and American studies. 
A systematic review was conducted in 2006 by a group in Nigeria7. It featured articles that were 
published between 1944 and 2004. These studies emanated from 13 African countries, including 
South Africa. The review showed that incidence and prevalence rates of IPD appeared lower in Africa 
than those in Europe and North America. There were few genetic studies done in Africa, and none in 
blacks. 
 
In 2010, the same group published a study that investigated the clinical profile of Parkinson’s Disease 
in a population of patients in Lagos, Nigeria8. These results were extracted from a data base collected 
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over 10 years. Of the 124 patients with parkinsonism, 98 (79%) had Idiopathic Parkinson’s Disease, 
while 26 (21%) had secondary PD. Results showed a similar disease profile to European counterparts, 
although there were fewer patients with early onset disease (<50 years old) and family history. Only 
1,02%  of all patients had a family history of PD. The frequency of young onset PD was 16.3%.  In 
terms of clinical presentation, 31.6% were tremor- predominant, 55.1% were mixed, and 14.3% had 
an akinetic-rigid presentation. These different clinical presentations were not compared for gender. 
An important observation was that, compared to European studies, there was a greater delay in 
diagnosis. One of the negative aspects of this study was that patients with secondary Parkinson’s 
disease were not excluded from the study. 
Of the few studies that have come out of Africa, most have been prevalence studies. J.E. Cosnett 
published an observational study in 19889 which included 2638 patients from 3 major centres in 
Durban, South Africa. This was the first of its kind in South Africa. The prevalence of IPD was 
determined by calculating the frequency of levodopa usage. The results showed a lower prevalence of 
IPD in Black patients compared to White patients. 
 
 Van Der Merwe, et al. looked at the factors influencing the development of early onset (EOPD) or 
late onset Parkinson’s Disease (LOPD)10. This data was extracted from a 5 year genetic study in 
Tygerberg Hospital in the Western Cape, South Africa. The study found that there is a high frequency 
of PD with early onset and positive family history in South Africa. EOPD was also found more 
frequently in Black, mixed-ancestry and White Afrikaner participants compare to White English 
speaking patients. This conflicts with the Lagos study’s findings.  A family history was associated 
with younger onset. However, one third of cases with LOPD had a significant family history. This 
challenges the assumption that LOPD is sporadic. Gender was found to have no effect on Age of 
onset. This was in keeping with other  recent literature. Among participants, there was a male 
predominance. There were 62.5% more males with PD than females. Coffee and cigarette smoking 
had no impact. There were no definitive findings regarding environmental factors.  
In terms of environmental risk factors, some metals and pesticides have been linked to the 
development of PD in people with chronic occupational exposure. The Farming and Movement 
Evaluation Study (FAME)11, examined the relationship between PD and exposure to pesticides. This 
was a case-control study based in the United States  with participants recruited between 1993 and 
1997 from people with occupational exposure to pesticides and their spouses. A link was found 
between rotenone and paraquat and PD. This has been explained by mitochondrial dysfunction, 
oxidative stress, and the ubiquitin-proteosome  pathway  dysfunction. In 2000, Betarbet et al 
published experimental findings in rats that showed the presence of ubiquitin and alpha synuclein 
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containing cytoplasmic inclusions12. This was in response to rotenone treatment. Rotenone is 
commonly found in pesticides.  
Haaxma, C et al. Published a study in 200713, to investigate gender differences in disease 
characteristics. Motor deterioration and nigrostriatal degeneration in Idiopathic Parkinson’s Disease. 
The study sample included 253 participants with Parkinson’s Disease who had not received treatment 
with either dopamine agonists or levodopa. Age of onset, presenting symptoms, severity and 
progression of motor features, and the amount and progression of nigrostriatal degeneration were all 
assessed. These factors were then compared to determine the influence of gender and oestrogen status. 
The results revealed that women had a slightly older mean age of onset (2.1 years). This may have 
been related to higher physiological striatal dopamine levels, possibly related to the influence of 
oestrogen. Women had and a higher prevalence of tremor and a milder deterioration, suggesting a 
more benign disease course.  
Mayeux, R et al. carried out a population-based study to determine the prevalence of idiopathic 
Parkinson’s Disease, in Washington Heights in New York14. The study was conducted from January 
1988 to December 1993. A registry of patients with IPD was created by advertising on radio and 
television. Patients with and without dementia were included in the study.  The prevalence of IPD in 
99.4 per 100 000. This increased from 2.3 per 100 000 for patients younger than 50 years old, to 787.1 
per 100 000 in those older than 80 years old. The study concluded that Idiopathic Parkinson’s Disease 
was a frequent disease of the elderly. It affected men more than women, and White people more than 
non-white people.  
In October 2005, Baba et al, published the results of a large clinic-based cohort study which 
determined whether there were gender differences in the phenotype of Idiopathic Parkinson’s 
Disease15. Demographic, historical and clinical features were examined for differences between the 
two gender groups. A total of 1264 of individuals with IPD were assessed. The study sample was 
made up predominantly males (67%). There were no significant differences between the two groups, 
in terms of demographics and patient history. The frequency of a family history was also the same. 
The females in the sample did show a more advanced disease, as determined by the Hoen & Yahr 
staging. Females also had more severe dyskinesias as a result of Levodopa treatment. In terms of non-
motor symptoms of IPD, a history of depression was much higher in females, compared to males 
(35% vs. 24%). This study did more to highlight more the similarities between the two gender groups, 
than differences. 
In 2012 in Sardinia, Solla, et al. investigated whether gender played a significant role in the 
development and progression of Parkinson’s disease16. 156 outpatients with Parkinson’s disease were 
recruited into the study. 91 were male and 65 were female. The two groups were assessed for 
differences in motor and non-motor symptoms of IPD. The results showed that, in terms of motor 
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symptoms, females were more likely to present with tremor as the first symptom, compared to males. 
There were many differences between the two groups in terms of non-motor symptoms. With regards 
to autonomic dysfunction, the severity of cardiovascular involvement was worse in females, whereas 
sexual dysfunction was more frequent in males. Abnormal mood, usually depression, and anxiety 
were more common in females, however males showed more impulsive behaviour. This study 
highlighted the role that gender plays in the presence of motor and non-motor aspects of Idiopathic 
Parkinson’s disease.   
So far, studies of Parkinson’s Disease in African populations have shown a lower incidence and 
prevalence compared to European and North American populations. The findings regarding the 
frequency of Early onset PD in Black patients has been inconsistent.  A family history of PD is 
associated more frequently with a younger onset, but is found in a significant percentage of LOPD as 
well. There is also a greater delay in diagnosis of PD in Africa.  
 
7) Objective  
The purpose of this study is to describe the population of patients with Idiopathic Parkinson’s Disease 
who attend the Neurology clinic at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) and 
Chris Hani Baragwanath Hospital (CHBH). The description will include demographic information as 
well as clinical features, comorbidities, and treatment response. This will then be compared to the 
well documented European and North American populations in terms of age of onset, gender 
predominance, family history, most prominent clinical features etc. This is to determine whether IPD 
in our group of patients differs in any way to the well described Northern Hemisphere PD 
populations. Furthermore, the study is aimed at determining whether ethnicity and gender have any 
impact on the clinical presentation of IPD. There is anecdotal evidence that black patients may present 
with a distinctive clinical phenotype. The study will determine whether this is the case in our 
population of patients. 
 
8) Method  
(i) Study design and study population: This is an observational study using a questionnaire 
as well as cognitive testing by means of the Mini Mental State examination, grading of 
motor function with the Hoen and Yarh score, and grading of physical disability. The 
study will run from when final ethics approval is received, until 50 participants who meet 
the inclusion criteria are recruited. The questionnaire will be administered to both new 
and old patients with Parkinson’s Disease who attend the Movement disorder/Parkinson’s 
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clinic every Friday at Charlotte Maxeke Johannesburg Academic Hospital. Each patient 
will have to sign consent to allow their information to be used in this study. The questions 
posed will cover demographic information, details regarding onset of symptoms of 
Parkinson’s Disease, and exposure to environmental toxins which have been previously 
linked to PD. The questionnaire will be followed by a mini-mental examination and their 
illness will be graded using the Modified Hoen and Yahr criteria. Once the data is 
collected it will be used to describe the general profile of our PD patients. The findings 
will then be compared to previous descriptions in Africa as well as Europe and North 
America. 
 
(ii) Materials 
Questionnaire 
The questionnaire will include basic demographic information, including  
• age,  
• age of onset,  
• race,  
• gender 
• level of education, 
• occupation, 
• toxin exposure, 
• comorbidities, 
• History of head injury, 
• As well as clinical features such as tremor, pattern of rigidity, falls, posture. 
 
The Modified Hoehn and Yahr scale (H&Y): 
 
This is an IPD rating scale which broadly classifies areas of motor dysfunction in patients with PD. It 
is widely used.  It was originally published in 196717. It includes stages 1 to 5. Since then, a modified 
Hoen and Yahr scale was developed, which added stages 1.5 and 2.518. These helped in describing the 
intermediate course of the disease. Of all the rating scales it is the most simple to apply. Progression 
in the H&Y score has been found to correlate closely with progression in physical disability. It 
focuses only on motor aspects of PD. The disadvantage of this test is that it fails to evaluate non-
motor aspects of PD. Cognitive involvement in PD patients will be assessed using the Mini Mental 
State Examination. 
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Mini Mental State Examination: 
The mini mental state examination (MMSE), also known as the Folstein test, is a 30-point 
questionnaire that is used extensively in clinical research to assess for cognitive impairment19. It was 
introduced by Folstein et al. in 1975, to help differentiate between organic and psychiatric patients. 
The MMSE  is a simple and easily reproducible test for signs of cognitive impairment. Other 
advantages are that it requires no specialised equipment or training. 
The test examines functions such as orientation, registration, attention, calculation, language, recall, 
and the ability to follow simple commands. Although it is not very sensitive for early signs of 
cognitive dysfunction, it has the advantage of not being culture specific. However, the test requires 
that the participant has a grade eight level of education, and is fluent in English. A MMSE score of 
less than 25 is considered as cognitive impairment. 
 
Scwab and England Activities of Daily Living Scale: 
This is another tool used to grade disability, in terms of how it impacts daily life20. 
 
Parkinson’s Disease Questionnaire:  
The questionnaire was designed to be simple to use as the examiner but also to be thorough enough to 
extract all the necessary information from patients. Wherever possible, questions are simplified so that 
an answer can be given as either a “yes” or “no” type questions or the answer can be selected from a 
list of possible answers. Symptoms and signs are graded in terms of severity on a scale of 1 to 5. This 
is all to ensure that data can be easily extracted and put into categories and that no information is left 
out. 
 
(iii) Inclusion and exclusion criteria: All patients who attend the neurology and Movement 
Disorder clinics will be offered participation in the study. Included in the study will be 
patients previously or newly diagnosed with IPD, who have met the QSBB criteria for 
diagnosis of IPD.  
 Patients excluded in the study will be those who are known to have secondary PD i.e. as 
a result of a vascular event or use of neuroleptic drugs, or those with clinical features of a 
Parkinson’s Plus syndrome.  
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Informed consent 
 
All patients who qualify to participate in the study, with counselled as to the purpose of the study, 
confidentiality of medical information, and the right to refuse participation. Each participant will then 
have to sign a consent form in order to participate in the study. The consent form is attached. 
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Consent form for participation in the following study: 
 
The Clinical profile of Idiopathic Parkinson’s Disease in a South African Hospital Complex. A 
prospective Observational study. 
 
Principal investigator: Dr M Smith 
Supervisor: Prof. G Modi 
Division of Neurology 
 
I……………………………………………………………………………………………….. 
understand that my participation in this study is voluntary and that the information will be kept 
anonymous. The details of the research process have been explained to me. I have had an opportunity 
to ask questions and have had them answered to my satisfaction. I hereby consent to participation in 
this research project. 
 
Participant’s signature…………………………………………………                          
Date…………………………. 
 
Witness ……………………………………………………… 
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                               PARKINSON’S DISEASE RESEARCH  
 
         FACT SHEET 
My name is Dr Marcelle Smith. I am a registrar in the Department of Neurology. I am doing 
my MMED research project on Parkinson’s disease (PD). The study is entitled 
“The Clinical Profile of Idiopathic Parkinson’s Disease In A South African 
Hospital Complex. A Prospective Observational Study.” 
• The aim of this study is to understand the characteristics of PD in our population of patients that attend 
neurology clinics at Chris Hani Baragwanath Hospital and Charlotte Maxeke Hospital. 
 
• The data collection involves completion of a questionnaire. This covers demographic information such 
as age, race, highest level of education, occupation and previous medical history. 
 
 
• There are also questions concerning the PD itself, including time of diagnosis, family history, 
symptoms and signs and exposure to environmental toxins.  
 
• The questionnaire is followed by a Mini Mental State Examination, which tests higher mental functions 
such as memory. 
 
 
• Each participant then has their PD graded by the Hoen and Yahr scoring system followed by a 
disability scoring. 
 
• The study does not involve any changes in treatment or any lab tests. 
 
 
• Participation in this study is completely voluntary. Each person will be asked to sign consent before the 
information can be used. All information is kept anonymous. Each participants information is marked 
with a code which is made up of their initials and year of birth e.g. NM53 to ensure this. 
 
For further information, please contact me on 011 488 4911 
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A.  Parkinson’s Questionnaire 
1. Participant code: 
2. Gender:                           □male                        □   female 
3. Race:                          □ black                       □ white                      □ coloured                                           
□indian                      □ other, specify……………………………………………… 
4. Highest level of education: 
5. Dominant hand           □ right                                             □ left       
6. Current/ previous occupation: 
7. Family history of Parkinson’s Disease                    □ Yes                   □ No 
8. Social habits          □ cigarettes      □  alcohol         □ caffeine      □ illicit drugs, specify 
9. Age of onset of symptoms: 
10. Time taken for diagnosis to be made:                   
11. Side of first symptoms:           □ Right              □Left 
12. Symptoms and signs 
Tremor:    3-5Hz.□      >5Hz.□     
Rigidity:  Axial.□              Appendicular.□     
Gait:     Bradykinesia.□       Festinating.□                Magnetic .□    
Postural instability:          Orthostatic hypotension.□                Falling.□     
Posture:   Erect.□   Stooped.□      Degree of kyphosis. □  
Ocular:    Abnormal saccades   □            Impaired upgaze□ 
13. Exposure to toxins- Heavy metals:       □ iron    □Manganese      □Lead     □copper     
□type unknown     □other, 
specify………………………………………………………………….. 
 □pesticides/herbicides   ( paraquat     □yes     □no     □unknown)     
14. Psychiatric illness:  □ no   □ yes, type……………………………….. 
15.  Psychiatric medication:   □ SSRI’s            □ TAD                □ Antipsychotics        
16. Previous head injury:      □ yes    □no    
17. Previous stroke:          □ yes    □no 
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18. Other neurological diagnoses     □ yes    □no    if yes, 
type………………………………………………… 
19. Comorbidities       □HPT         □ DM         □ Dyslipidaemia    □none    □other   
………………… 
20. PD treatment      □  carbilev        □ pexola        □ symmetral       □none                        
□other, specify……………… 
21. Are you satisfied with your treatment        □ yes    □no 
22. Hoen and Yahr score 
B. Stage  Modified Hoehn and Yahr Scale 
□1 Unilateral involvement only 
□1.5 Unilateral and axial involvement 
□2 Bilateral involvement without impairment of balance 
□2.5 Mild bilateral disease with recovery on pull test 
□3 Mild to moderate bilateral disease; some postural instability; physically independent 
□4 Severe disability; still able to walk or stand unassisted 
□5 Wheelchair bound or bedridden unless aided 
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Mini-Mental State Examination (MMSE) 
 
 
 
Patient’s Name:         Date:     
 
Instructions: Ask the questions in the order listed. Score one point for each correct 
response within each question or activity. 
 
Maximum 
Score 
Patient’s 
Score 
Questions 
5  “What is the year?  Season?  Date?  Day of the week?  Month?” 
5  “Where are we now: Sta te?  County?  Town/city?  Hospital?  Floor?” 
3  
The examiner names three unrelated objects clearly and slowly, then 
asks the patient to name all three of them. The patient’s response is 
used for scoring. The examiner repeats them until patient learns all of 
them, if possible. Number of trials: _ __________ 
5  
“I would like you to count backward from 100 by sevens.” (93, 86, 79, 
72, 65, …) Stop after five answers. 
Alternative: “Spell WORLD backwards.” (D-L-R-O-W) 
3  
“Earlier I told you the names of three things. Can  you tell me what those 
were?” 
2  
Show the patient two simple object s, such as a wristwatch and a pencil, 
and ask the patient to name them. 
1  “Repeat the phrase: ‘No ifs, ands, or buts.’” 
3  
“Take the paper in your right hand, fold it in half, and put it on the floor.” 
(The examiner gives the patient a piece of blank paper.) 
1  
“Please read this and do what it says.” (Written instruction is “Close 
your eyes.”) 
1  
“Make up and write a sentence about anything.” (This sentence must 
contain a noun and a verb.) 
1  
“Please copy this picture.” (The examiner gives the patient a  blank 
piece of paper and asks him/her to draw the symbol below. All 10 
angles must be present and two must intersect.) 
 
 
 
30  TOTAL 
(Adapted from Rovner & Folstein, 1987)
Source: www.medicine.uiowa.edu/igec/tools/cognitive/MMSE.pdf Provided by NHCQF, 0106-410
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Schwab and England Activities of Daily Living Scale:  
1. □100% = Completely independent. Able to do all chores without slowness, difficulty or 
impairment. Essentially normal. Unaware of any difficulty. 
2. □90% = Completely independent. Able to do all chores with some degree of slowness, 
difficulty and impairment.  Might take twice as long. Beginning to be aware of difficulty. 
3. □80% = Completely independent in most chores. Takes twice as long. Conscious of 
difficulty and slowness. 
4. □70% = Not completely independent. More difficulty with some chores. Three to four times 
in some. Must spend a large part of the day with chores. 
5. □60% = Some dependency. Can do most chores, but exceedingly slowly and with much 
effort. Some impossible. 
6. □50% = More dependent. Help with half, slower, etc. Difficulty with everything.  
7. □40% = Very dependent. Can assist with all years, but few alone. 
8. □30% = With effort, now and then does a few chores alone or begins alone. Much help 
needed. 
9. □20% = Nothing alone. Can be a slight help with some chores. Severe invalid.  
10. □10% = Totally dependent, helpless. Complete invalid. 
11. □0% = Vegetative functions such as swallowing, bladder and bowel  functions are not 
functioning. Bedridden.  
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Abstract: 
Idiopathic Parkinsons Disease (IPD) has not been well studied in Black African populations. 
Data on the demographics, phenotype differences with Caucasoid populations, severity and 
frequencies of IPD in Black Africans is scant.  
 
Aim: to determine the impact of ethnicity and gender on the phenotype of IPD in South 
African patients. 
 
Method: Fifty patients with diagnosed IPD were recruited. The data collection was in the 
form of a questionnaire and clinical evaluation which included a mental status examination 
(MMSE), and illness staging.  
 
Results: Thirty-five patients were Black African, eleven were white European descendant, 
three were of Indian descent and one had mixed ancestry. Twenty-eight of the patients were 
female. There were no significant gender differences within or between the different ethnic 
groups. Seventy- one percent of black and ninety-one percent of white participants had 
classic IPD presentations. A resting tremor was found in fifty-nine percent of all males in the 
study but in ninety-four percent of females. In the black IPD patients, thirty-one percent had 
early onset IPD (age of onset less than 50 years) with a gender ratio of M:F=1:6. Twenty-nine 
percent had an akinetic-rigid syndrome with erect posture and no tremor (gender ratio of M:F 
= 7:4) and seventy-four had cognitive impairment (gender ratio of M:F =8:5). 
 
Conclusion: The phenotype of IPD in the majority of our study population is of the classic 
IPD type. In a third of our Black patients the onset was early and in a third the presentation 
was akinetic. 
 
Keywords: Parkinsons disease; Gender; Ethnicity 
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Introduction 
 
The classic profile of Idiopathic Parkinsons Disease is based on the data derived from 
European and North American populations. Little is known about IPD in people of African 
origin.  
There have been a few studies investigating Idiopathic Parkinsons Disease in African 
American populations. In a study from Northern California, USA in 20031, the relationship 
between race and gender in patients with IPD was reported. The results showed an older age 
of onset in Whites compared to Blacks, Hispanics and Asians. The incidence of IPD was 91% 
higher in men than in women. A cross-sectional epidemiological study conducted across the 
USA in 20102 of US Medicare beneficiaries aged 65 and older, showed that there was a 50% 
lower incidence of IPD in Blacks compared to Whites.  
In Africa, a systematic review reported from a Nigerian group in 20063 featuring articles that 
were published between 1944 and 2004 from 13 African countries, including South Africa 
concluded that the incidence and prevalence rates of IPD appeared lower in Africa than those 
in Europe and North America. In 2010, the same group published a study that investigated 
the clinical profile of Parkinsons Disease in a population of patients in Lagos, Nigeria4. These 
results were extracted from a data base collected over 10 years. Of the 124 patients with 
parkinsonism, 98 (79%) had Idiopathic Parkinsons Disease, while 26 (21%) had secondary 
PD. Results showed a similar disease profile to European counterparts, although there were 
fewer patients with early onset disease (<50 years old) (16.3%) and family history (1,.02%). 
In terms of clinical presentation, 31.6% were tremor- predominant, 55.1% were mixed, and 
14.3% had an akinetic-rigid presentation. These different clinical presentations were not 
compared for gender. An important observation was that, compared to European studies, 
there was a greater delay in diagnosis. One of the negative aspects of this study was that 
patients with secondary Parkinsons disease were not excluded from the study. 
The first study on IPD in the black South African population was published in 19885. These 
results were derived from monitoring the prevalence of levodopa usage. The study concluded 
that IPD occurred less frequently in Black Africans. In terms of recent data, a study from 
Tygerberg Hospital in the Western Cape, South Africa, investigated the factors influencing 
the development of early onset (EOPD) or late onset Parkinsons Disease (LOPD), 6. This data 
was extracted from a 5-year genetic study. Of the 397 patients, 62.5% (248) were male, and 
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34,8% (138) were female. Gender was found to have no effect on age of onset. EOPD was 
also found more frequently in Black, mixed-ancestry and White Afrikaner participants 
compare to white English speaking patients. This conflicts with the Lagos study’s findings.  A 
family history was associated with younger onset. However, one third of cases with LOPD 
had a significant family history.  
No studies have looked specifically at whether there are different clinical phenotypes of IPD 
among different ethnic groups. 
 
  
 36 
Aim: 
 
The aim of this study was to determine whether ethnicity and gender have any influence on 
the clinical presentation of patients with IPD who attend the Neurology clinic at Charlotte 
Maxeke Johannesburg Academic Hospital (CMJAH) and Chris Hani Baragwanath Hospital 
(CHBH) compared with the published European and North American clinical phenotypes.   
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Method: 
 
Study design and study population:  
This was an observational study conducted in two parts: a questionnaire and clinical evaluation.  
The questionnaire (appendix 1) consisted of 22 questions pertaining to demographic information 
such as age, gender, race and clinically relevant history such as age of onset, family history, time to 
diagnosis, and the presence of specific symptoms.  
The second component consisted of a series of clinical examination and a series of tests, namely, the 
Mini Mental State examination7  (grading of cognitive impairment), the Hoehn and Yahr score 8;9 
(grading of physical disability) and Schwab and England activities of daily living scale (S&E)10.   
The study population consisted of patients known with Idiopathic Parkinson’s Disease who 
attend the Movement disorder/ Neurology clinics at Charlotte Maxeke Johannesburg Academic 
Hospital and Chris Hani Baragwanath Hospital in Johannesburg, South Africa. We offered 
participation to all the patients who visited the clinic during the study period.  
Inclusion criteria:  
A diagnosis of Idiopathic Parkinson’s Disease (IPD) in keeping with the Queen Square Brain 
Bank (QSBB) criteria11. This is a universally accepted list of diagnostic criteria for IPD12.  
Able to give consent 
Sufficient level of education to complete the MMSE 
Exclusion criteria: 
           Secondary Parkinson’s Disease due to neuroleptic drugs, vascular lesions. 
Cognitive impairment too severe to enable consent for participation in 
the study 
Refusal of participation 
Features of a Parkinson’s-Plus syndrome 
A total of 50 patients met the inclusion criteria during the recruitment period.  
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The demographic and clinical data gathered was tabulated in an excel spread sheet and descriptive 
and inferential statistics we performed using SPSS software.  
The findings were then compared to previous descriptions in Africa as well as Europe and North 
America. 
For purposes of this study,  
• Early onset Parkinson’s Disease (EOPD) is defined, according to literature, 
as Age of Onset (AOO) of 50 years or younger. 
• Cognitive impairment is defined as a MMSE score of less than 25. 
• Erect posture is defined as an angle of spinal kyphosis less than 20 degrees, 
and a stooped posture as an angle of more than 40 degrees13. 
• Time to diagnosis will be abbreviated as TTDx. 
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Results: 
50 patients were included in the study. Thirty-five (70%) were Black African, eleven (22%) 
were of European descent, three (6%) were of Indian descent, and one (2%) had mixed-
ancestry. There was a slight female preponderance of 56%. The mean age of the participants 
was 63 years old (range 36-83). There were several clear trends that came to the fore when 
comparing race and gender groups. The clearest differences were in age of onset, posture, 
rigidity, and tremor. However, not all of the differences proved to be statistically significant. 
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Table 1: Demographic and illness staging differences. 
 
 
 
Black n=35 White n=11 P-value 
 Mean  Range 95% CI  
 
 
 
 
 
 
 
 
 
 
 
 Mean  Range  95%CI    
Age 60.8 51-76 55,8:65,8 Age 67,2 44-83 61,6:7
2,8 
 0.089  
AOO 54.31 12-78 49,6:59 AOO 60,7 43-78 53,5:6
7,9 
 0,164  
TTDx 20,3 0-120 53.5-67.9 TTDx 56,7 0-360 22,8:1
36,3 
 0,33  
MMSE 25 15-90 20.9:29:2 MMSE 24,6 13-30 20,9:2
8,3 
 1,0  
H&Y 2,5 1-5 2,2:2,8 H&Y 2,45 1-5 1,6:3,
3 
 0,75  
S&E 61.8 10-90 53,6:70,0 S&E 66 20-90 43,1:8
9 
 0,51  
 
AOO= age; TTDx= Time to diagnosis; MMSE= Mini mental state examination; H&Y= Hoen and Yahr score; S&E= 
Schwab and England activities of daily living scale.   
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Table 2: Descriptive analysis for black versus white patients. 
 
 
 Symptom Prevalence  Significance of Difference  
 Black n(%) White n(%) p-value Likelihood 
ratio (LR) 
 
Appendicular rigidity 19 (54,3) 10(90,1) 0.033* 5,95  
Axial rigidity 28 (80) 4 (45,5) 0.34   
Stooped posture 
Erect posture 
11 (31,4) 
24 (68.6) 
8  (72,7) 
3 (27.3) 
0.039* 4.3  
Magnetic gait 32 (91,4) 0 1.0   
Festining gait 7 (20) 4 (36,4) 0.42   
bradykinesia 33 (94,3)  11(100) 1.0   
Falling 14 (40) 4 (36,40) 1.0   
Fam hx 3 (8,6) 2  (18,2) 0.58   
Tremor 9 (25,7) 100 0.42   
Orthostatic hypotension 5 (14,3) 0    
 
 
(* indicates statistical significance with a p-value of less than 0.05) 
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Table 3: Differences in symptom prevalence for gender. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(* indicates statistical significance with a p-value of less than 0.05) 
 
 Male Female P-value 
 Mean  95% CI Mean  95% CI  
Age 60,1 53,2:67 64,6 60,3:68,9 0,4 
AAO 56 50,5:61:5 56,5 51,1:61,8 0,9 
TTDx 33,8 0,2:67,5 22 10,2:33,4 0,4 
Mmse  26,4 19,5:33,3 24 22,6:25,3 0,42 
H&Y 2,5 2:3 2,5 2,1:2,9 1,0 
S&E 63,3 51,6:75,1 64,1 54,5:73,7 0,9 
    
 Prevalence of clinical signs (%) Comparison 
 Male Female p-value LR   
Appendicular rigidity 63,6 64,3 0.79    
Axial rigidity 95,5 64,3 0.34    
Stooped posture 50 39,3 0.60    
Magnetic gait 5 7 1.0    
Festining gait 27,3 25 1.0    
bradykinesia 100 93,9 0.50    
Falling 36,4 42,9 0.60    
Fam hx 9 17,9 0.24    
tremor 59,1 93,9 0.010* 7.7   
Orthostatic 
hypotension 
0 4     
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AOO= age; TTDx= Time to diagnosis; MMSE= Mini mental state examination; H&Y= Hoen and Yahr score; S&E= 
Schwab and England activities of daily living scale; Fam hx= Family history.  
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Table 4: Chief clinical differences found in this study. 
 
 
 BLACK WHITE 
 MEAN AAO 56,6 60,7 
%EOPD 31 18 
%COGNITIVE 
IMPAIREMENT 
74 18 
%AKINETIC-RIGID 
SYNDROME 
29 9 
%CLASSIC IPD 71 91 
   
 
AOO= Age of onset; EOPD= early onset Parkinsons Disease. 
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Discussion 
 
 
The aim of this study was to look at whether ethnicity and gender have a significant impact 
on the clinical presentation of Idiopathic Parkinson’s Disease (IPD) in our patient population. 
To date, there have been no notable studies exploring possible differences in disease 
phenotype between Black and White patients.  
Our study was conducted in a highly specialized clinic in a tertiary hospital, which serves a 
largely indigent population. As a result, we cannot draw conclusions on the prevalence of 
IPD, or differences in cognitive impairment. When comparing the different ethnic and gender 
groups, our study showed clear trends with regards to differences in phenotypes. The main 
differences seen were in age of onset, pattern of rigidity, posture and tremor.  
 
Ethnicity: 
The majority of patients in our study population had the classic presentation of IPD. This is a 
syndrome of late onset, resting tremor, stooped posture, appendicular rigidity, and 
bradykinesia. This included ninety-one percent of White and seventy-one percent of Black 
patients. However, a subset of patients, particularly Black patients, showed some deviations 
from the classic phenotype.  
IPD is typically a disease of the elderly but modern literature describes an earlier disease 
onset in patients of African origin (1;6). This was replicated in our study. One third of Black 
patients had early onset Parkinson’s disease (EOPD) compared to eighteen percent of White 
patients. 
 
Of note, Black patients were more likely to have axial (80%) rather than appendicular rigidity 
(54.3%) compared to White patients (45.5% and 90.1% respectively.) They were also more 
likely to have an erect posture (68.6%). These two findings were statistically significant (p-
values= 0,033 and 0,039 respectively). 
Furthermore, almost a third of Black patients had an akinetic-rigid presentation. This was 
particularly prevalent in Black males (54%). 
There was a higher incidence of cognitive impairment in black patients. It is important to note 
that, although all participants had a sufficient level of education to complete the MMSE, there 
may have been some bias because of differences in the quality of education, a legacy of the 
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country’s history of racial inequality. It is important to note that the MMSE has a culture bias 
and is not specific for features of a subcortical dementia, which is found in IPD. However, it 
is a good screening tool and is easily reproducible.  
 
Gender: 
There were also several differences in presentation between the two gender groups. There 
was a slight female preponderance of 56%, unlike the male preponderance described in 
literature. The clinical phenotype was similar between the two groups except for two marked 
differences. Firstly, the prevalence of axial rigidity was greater in males (95,5%) compared to 
females (64,3%). Secondly, the prevalence of a resting tremor was much higher in females 
(93,9%), compared to males (59,1%). This was statistically significant (p value= 0,01). The 
mean age of onset (AOO) was similar in male and female participants in both racial groups.  
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Conclusion 
 
The phenotype of IPD in the majority of our study population is of the classic type. A third of 
our Black patients had EOPD. We identified a subset of Black patients (one third) who 
presented with an akinetic-rigid syndrome. 
 
Although the results showed clear trends in the differences between race and gender groups, 
they were not all statistically significant. This is possibly due to the small sample size and 
hospital complex bias. A larger sample size and community study is needed to confirm these 
findings.  
 
Limitations:  
Our sample size was small and limited to one geographical area.  
Although the recruitment time was sufficient, our sample size was biased by the fact that 
many patients at the movement disorder clinics had secondary Parkinsons disease. Several 
were too cognitively impaired to provide consent, and there were also many with insufficient 
schooling to perform cognitive testing. 
The Hospitals in which the study was conducted serve more Black than White patients. As a 
result, more Black patients were recruited into the study. 
 The MMSE is a good screening tool but isn’t designed for subcortical dementia which is 
found in IPD. It has a culture bias as well. MMSE scores have been shown to be lower in 
Black and other ethnic groups due to differences in English proficiency and socioeconomic 
factors14. 
 
A more expansive study is needed to validate our results. 
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Figures: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Ethnic distribution of sample. 
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Figure 2: Mean age of onset. 
%EOPD= percentage of early onset Parkinson’s disease. 
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Figure 3: Percentage with cognitive impairment. 
MMSE= mini mental state examination 
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Figure 4: Percentage with Akinetic-rigid syndrome. 
 
 
 
 
 
 
 
 
 
 
 
 
29%
9%
0% 0%
54%
14%
0% 0%
18%
0% 0% 0%
0%
10%
20%
30%
40%
50%
60%
Black White Coloured Indian
Overall
Male
Female
 55 
5. Corrections  
1. Line 19: “criterion in” changed to “criterion is” 
2. Line 22: “postural stability” changed to “postural instability” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
